Royal Bank Of Canada Bio Rad Laboratories, Inc. Transaction History

Royal Bank Of Canada

  • $528 Billion
  • Q2 2025

A detailed history of Royal Bank Of Canada transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 151,558 shares of BIO stock, worth $41.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
151,558
Previous 30,310 400.03%
Holding current value
$41.6 Million
Previous $7.38 Million 395.43%
% of portfolio
0.01%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
BUY
$216.56 - $256.68 $26.3 Million - $31.1 Million
121,248 Added 400.03%
151,558 $36.6 Million
Q1 2025

May 15, 2025
BUY
$243.0 - $367.0 $1.48 Million - $2.24 Million
6,100 Added 25.2%
30,310 $7.38 Million
Q4 2024

Feb 14, 2025
BUY
$313.15 - $374.28 $227,033 - $271,353
725 Added 3.09%
24,210 $7.95 Million
Q3 2024

Nov 14, 2024
SELL
$263.97 - $344.64 $1.03 Million - $1.34 Million
-3,894 Reduced 14.22%
23,485 $7.86 Million
Q2 2024

Nov 06, 2024
SELL
$268.26 - $339.48 $35,678 - $45,150
-133 Reduced 0.48%
27,379 $7.48 Million
Q2 2024

Aug 14, 2024
SELL
$268.26 - $339.48 $1.17 Million - $1.49 Million
-4,378 Reduced 13.73%
27,512 $7.51 Million
Q1 2024

Nov 05, 2024
BUY
$304.11 - $351.99 $1.29 Million - $1.49 Million
4,245 Added 15.43%
31,757 $11 Million
Q1 2024

May 15, 2024
SELL
$304.11 - $351.99 $218,350 - $252,728
-718 Reduced 2.2%
31,890 $11 Million
Q4 2023

Feb 14, 2024
SELL
$269.37 - $365.04 $12.8 Million - $17.4 Million
-47,649 Reduced 59.37%
32,608 $10.5 Million
Q3 2023

Nov 14, 2023
BUY
$350.25 - $422.63 $581,415 - $701,565
1,660 Added 2.11%
80,257 $28.8 Million
Q2 2023

Aug 14, 2023
SELL
$359.49 - $486.4 $2.49 Million - $3.37 Million
-6,919 Reduced 8.09%
78,597 $29.8 Million
Q1 2023

May 15, 2023
BUY
$418.69 - $503.0 $3.44 Million - $4.14 Million
8,228 Added 10.65%
85,516 $41 Million
Q4 2022

Feb 14, 2023
BUY
$351.71 - $456.01 $3.83 Million - $4.97 Million
10,890 Added 16.4%
77,288 $32.5 Million
Q3 2022

Nov 14, 2022
BUY
$412.59 - $563.26 $3.94 Million - $5.38 Million
9,543 Added 16.78%
66,398 $27.7 Million
Q2 2022

Aug 15, 2022
BUY
$463.67 - $597.16 $159,038 - $204,825
343 Added 0.61%
56,855 $28.1 Million
Q1 2022

May 16, 2022
BUY
$524.57 - $735.42 $3.58 Million - $5.01 Million
6,819 Added 13.72%
56,512 $31.8 Million
Q4 2021

Feb 14, 2022
SELL
$708.84 - $794.68 $1.98 Million - $2.21 Million
-2,787 Reduced 5.31%
49,693 $37.5 Million
Q3 2021

Nov 15, 2021
SELL
$657.71 - $825.77 $2.75 Million - $3.45 Million
-4,175 Reduced 7.37%
52,480 $39.1 Million
Q2 2021

Aug 16, 2021
BUY
$576.64 - $649.04 $32.7 Million - $36.8 Million
56,655 New
56,655 $36.5 Million

Others Institutions Holding BIO

# of Institutions
427
Shares Held
19.1M
Call Options Held
10.7K
Put Options Held
37.5K
View Full List

About BIO-RAD LABORATORIES, INC.

BIO Quotes by TradingView
  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $6.77B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email